Ocrelizumab


Study Exclusion reasons Rmk Reference
Vukusic, 2017 inadequate or absent control group

Vukusic European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Online Library 2017.

- About - Master protocol - Browse exposition - RSS - Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons